Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities
Advanced Materials · 2024
DOI: 10.1002/adma.202308760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Xichi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Brigham and Women's Hospital, Boston, MA, 02115, USA. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Bioengineering strategies for the fabrication of implantable lymphoid structures mimicking lymph nodes (LNs) and tertiary lymphoid structures (TLS) could amplify the adaptive immune response for therapeutic applications such as cancer immunotherapy. No method to date has resulted in the consistent formation of high endothelial venules (HEVs), which is the specialized vasculature responsible for naïve T cell recruitment and education in both LNs and TLS. Here orthogonal induced differentiation of human pluripotent stem cells carrying a regulatable ETV2 allele is used to rapidly and efficiently induce endothelial differentiation. Assembly of embryoid bodies combining primitive inducible endothelial cells and primary human LN fibroblastic reticular cells results in the formation of HEV‐like structures that can aggregate into 3D organoids (HEVOs). Upon transplantation into immunodeficient mice, HEVOs successfully engraft and form lymphatic structures that recruit both antigen‐presenting cells and adoptively‐transferred lymphocytes, therefore displaying basic TLS capabilities. The results further show that functionally, HEVOs can organize an immune response and promote anti‐tumor activity by adoptively‐transferred T lymphocytes. Collectively, the experimental approaches represent an innovative and scalable proof‐of‐concept strategy for the fabrication of bioengineered TLS that can be deployed in vivo to enhance adaptive immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Brigham and Women's Hospital, Boston, MA, 02115, USA.
- Harvard Medical School, Boston, MA, 02115, USA.
- Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Boston, MA, 02115, USA.
- Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 02118, USA.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, 02215, USA.
- Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA, 02138, USA.
ORCID-Profile: Dario R Lemos
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
Zitieren
APA
Wang, X., Li, X., Zhao, J., Li, Y., Shin, S. R., Ligresti, G., Ng, A. H. M., Bromberg, J. S., Church, G., Lemos, D. R., & Abdi, R. (2024). Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities. Advanced Materials. https://doi.org/10.1002/adma.202308760
Vancouver
Wang X, Li X, Zhao J, Li Y, Shin SR, Ligresti G, et al. Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities. Advanced Materials. 2024. doi:10.1002/adma.202308760
BibTeX
@article{Wang2024,
author = {Wang, Xichi and Li, Xiaofei and Zhao, Jing and Li, Yi and Shin, Su Ryon and Ligresti, Giovanni and Ng, Alex H M and Bromberg, Jonathan S and Church, George and Lemos, Dario R and Abdi, Reza},
title = {Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202308760}
}
EUVIMED